PreDxion Bio
South San Francisco
About PreDxion Bio
PreDxion Bio is an early-stage healthcare company revolutionizing testing and treatment through low-cost, user-friendly at-home diagnostics. Enabled by PreDxion’s proprietary multiplexed localized surface plasmon resonance (LSPR) technology, our first product is a rapid, saliva-based test for COVID-19, flu, pneumonia, common cold, and other respiratory diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $6.4M
- Funding stage: Seed
- Last round: Seed (Sep 2020)
- Website: predxionbio.com
- Phone: +1 -734-436-1050
Industries & Categories
Biotechnology, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/predxion-bio-26155 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.